Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $902 at Raymond James

April 29, 2026 12:35 PM
Raymond James analyst Chris Raymond lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $902.00 (from $910.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change